[
  {
    "id": "10665-385346",
    "type": "document",
    "title": "Cost-effectiveness of introducing the pneumococcal conjugate vaccine for children under 5 years in the Islamic Republic of Iran",
    "author": [
      {
        "literal": "Khadijeh Ezoji"
      },
      {
        "literal": "Mohsen Yaghoubi"
      },
      {
        "literal": "Marzieh Nojomi"
      },
      {
        "literal": "Sussan Mahmoody"
      },
      {
        "literal": "Seyed Mohsen Zahraie"
      },
      {
        "literal": "Maziar Moradi-Lakeh"
      },
      {
        "literal": "Sedigheh R. Tabatabaei"
      },
      {
        "literal": "Abdollah Karimi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          10,
          29
        ]
      ]
    },
    "publisher": "World Health Organization. Regional Office for the Eastern Mediterranean",
    "DOI": "https://doi.org/10.26719/emhj.19.039",
    "URL": "https://iris.who.int/handle/10665/385346",
    "language": "en",
    "abstract": "Background:\nPneumococcal disease caused by Streptococcus pneumoniae results in considerable mortality and morbidity. Pneumococcal conjugate vaccines (PCV), such as PCV-13, can prevent invasive pneumococcal disease and avoid disability and death. The cost of introducing PCV-13 in childhood immunization schedules should be assessed against the cost of pneumococcal diseases for each community.\nAims:\nThis study aimed to evaluate the cost–effectiveness of introducing PCV-13 in the national immunization programme for children under 5 years in the Islamic Republic of Iran.\nMethods:\nThe TRIVAC decision support model was used to estimate total costs of introducing PCV-13 and the disability-adjusted life years (DALYs)averted. The main pneumococcal diseases were considered—pneumonia, meningitis, acute otitis media, and non-pneumonia, non-meningitis infections—in terms of hospital admissions, outpatient visits and deaths. Local data were used to estimate costs.\nResults:\nPneumococcal disease is estimated to affect 18 713 211 children under 5 years (519 412 pneumonia, 18 148 116 acute otitis media, 6884 meningitis, and 38 799 non-pneumonia, non-meningitis)in 10 years (2014–2023)without use of the vaccine. Introduction of PCV-13 would prevent 4 900 084 cases of pneumococcal disease (190 849 pneumonia, 4 692 450 acute otitis media, 2529 meningitis, and 14 256 non-pneumonia, non-meningitis). Pneumococcal infection would cause 287 950 hospital admissions and 29 399 deaths; vaccination could avert 105 802 hospital admissions and 9997 deaths. The incremental cost–effectiveness was estimated to be US$ 1890 and US$ 1538 per averted DALY for the government and society respectively.\nConclusion:\nAccording to WHO-recommended thresholds for interpreting cost–effectiveness, introduction of PCV-13 for children under 5 years in the Islamic Republic of Iran would be cost-effective"
  },
  {
    "id": "10665-385346.page-011.1",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2009
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.2",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2009
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.3",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2014
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.4",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2012
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.5",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2016
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.6",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2015
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.7",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2015
        ]
      ]
    }
  },
  {
    "id": "10665-385346.page-011.8",
    "type": "document"
  },
  {
    "id": "10665-385346.page-011.9",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2015
        ]
      ]
    }
  }
]
